NCT01963312View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

May 31, 2018

Conditions
Transurethral Resection of ProstateArtery EmbolizationBenign Prostatic HyperplasiaLower Urinary Tract Symptoms
Interventions
PROCEDURE

Transarterial Supraselective Embolization of the prostate

PROCEDURE

Transurethral Resection of the prostate

Trial Locations (1)

31008

Complejo Hospitalario de Navarra, Pamplona

All Listed Sponsors
lead

Fundacion Miguel Servet

OTHER

NCT01963312 - Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. | Biotech Hunter | Biotech Hunter